Skip to main content
. 2017 Oct 12;14(6):7045–7048. doi: 10.3892/ol.2017.7174

Table II.

Tumor-free survival, relapse and survival rate.

Groups N Tumor-free survival (months) Relapse rate, n (%) Survival rate, n (%)
Control 50 8.4 17 (34.0) 35 (70.0)
Treatment 40 12.3 6 (15.0) 35 (87.5)
χ2 8.324 4.217 3.938
P-value 0.006 0.040 0.047